AbbVie Inc. logo

AbbVie Inc.

NYSE:ABBV

Overview | Financials
Company Name AbbVie Inc.
Symbol ABBV
Currency USD
Price 203.55
Market Cap 359,538,507,000
Dividend Yield 3.75%
52-week-range 135.85 - 207.32
Industry Drug Manufacturers—General
Sector Healthcare
CEO Mr. Richard A. Gonzalez
Website https://www.abbvie.com

An error occurred while fetching data.

About AbbVie Inc.

AbbVie Inc. is a global pharmaceutical company focused on discovering, developing, manufacturing, and selling innovative therapies. Their diverse portfolio offers treatments for various medical conditions. Notable products include HUMIRA, used for autoimmune and intestinal Behçet's diseases, and SKYRIZI, for moderate to severe plaque psoriasis in adults. They also offer RINVOQ for

Related Stocks

Eli Lilly and Company logo

Eli Lilly and Company

LLY

818.93 USD

Merck & Co., Inc. logo

Merck & Co., Inc.

MRK

101.88 USD

Pfizer Inc. logo

Pfizer Inc.

PFE

28.09 USD

Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc.

TMO

557.92 USD

Abbott Laboratories logo

Abbott Laboratories

ABT

118.6 USD

Danaher Corporation logo

Danaher Corporation

DHR

247.76 USD

Bristol-Myers Squibb Company logo

Bristol-Myers Squibb Company

BMY

54.32 USD

Medtronic plc logo

Medtronic plc

MDT

90.07 USD

Financials

Numbers are in millions USD

Numbers are in millions USD